Home/Clinical Trials
RecruitingPhase 3CT-2024-111
Solekizumab in children with plaque psoriasis
Plaque psoriasis · Immunology
Ages 4 to 17 years1,230 participantsBerlin, Germany, Boston, MA
RecruitingPhase 2CT-2023-108
CLV-226 in adolescents and adults with atopic dermatitis
Atopic dermatitis · Immunology
Ages 12 years and older370 participantsBerlin, Germany, London, UK +1 more
RecruitingPhase 1CT-2026-109
CAR-T cell therapy CLV-233 in refractory lupus
Systemic lupus erythematosus · Immunology
Ages 18 to 80 years50 participantsTokyo, Japan, Berlin, Germany +2 more
Active, not recruitingPhase 3CT-2024-107
Corvatinib in moderate-to-severe Crohn's disease
Crohn's disease · Immunology
Ages 18 to 75 years1,910 participantsMadrid, Spain, Berlin, Germany +2 more
Not yet recruitingPhase 2CT-2025-126
CLV-226 in prurigo nodularis
Prurigo nodularis · Immunology
Ages 18 to 75 years350 participantsBerlin, Germany, Chicago, IL +1 more
CompletedPhase 3CT-2025-110
Teravolumab in hidradenitis suppurativa
Hidradenitis suppurativa · Immunology
Ages 18 to 75 years3,000 participantsSeoul, South Korea, Tokyo, Japan +2 more
CompletedPhase 3CT-2025-130
Solekizumab every-12-weeks dosing study
Plaque psoriasis · Immunology
Ages 18 to 80 years2,680 participantsMadrid, Spain, London, UK +2 more
Study listings are fictional. Talk with your doctor before joining any clinical trial.